Obesity Trial, Recruiting NCT07467694 Sponsor: Joslin Diabetes Center Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07467694
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 45 years old at the time of joining the trial
  • People whose body weight (BMI) before pregnancy or in the first three months of pregnancy was in the range of 18.5 to 40 kg/m²
  • People carrying a single baby with no pregnancy complications
  • People who plan to breastfeed exclusively for more than 3 months, and — if this is not their first pregnancy — who successfully breastfed a previous baby
  • People whose pregnancy reaches full term, meaning between 37 and just under 42 weeks
  • People whose baby is born at a weight above the 10th percentile for their stage of pregnancy (confirm with trial site)

Who may not be able to join:

  • People for whom exercise at one month after birth would be medically inadvisable due to pregnancy-related reasons
  • People with a diagnosis of type 1 or type 2 diabetes that is not well controlled (HbA1c above 7%), or gestational diabetes that requires insulin treatment
  • People whose baby had restricted growth in the womb
  • People who experienced pre-eclampsia or other complications during pregnancy
  • People who use alcohol, cannabis, or tobacco
  • People whose baby has a known inherited condition affecting metabolism, hormones, or feeding and growth
  • People whose baby has significant physical abnormalities present from birth
  • People who have joint, bone, or muscle problems that would make exercising difficult

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 617-309-4554

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Joslin Diabetes Center
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
1 July 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Altered breast milk lipidome; Altered breast milk metabolome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov